Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors

Bone Marrow Transplant. 2017 Apr;52(4):627-629. doi: 10.1038/bmt.2016.330. Epub 2016 Dec 19.

L E Perez^{1

2}, H Fernandez^{1

2}, E Ayala^{1

2}, F Beato¹, A Neuger³, J Pidala^{1

2}, M J Schell⁴, C Anasetti^{1

2}

¹ Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
² Department of Oncologic Sciences, H. Lee Moffitt Cancer Center and Research Institute/University of South Florida College of Medicine, Tampa, FL, USA.
³ Translational Research Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
⁴ Department of Biostatistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

No abstract available

Publication types